Recent Updates
Recently added Catalysts
ACAD Positive Sentiment

Acadia Pharmaceuticals to Participate in the UBS Global Biopharma Conference 2026

Wednesday, October 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Acadia Pharmaceuticals announced its participation in the UBS Global Biopharma Conference 2026. The fireside chat is scheduled for November 17, 2026, at 12:40 p.m. GMT. A live webcast will be available on the company's website, with an archived recording accessible for one month post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Acadia Pharmaceuticals will participate in a major conference.
  • The event will include a live webcast for broader access.
  • An archived recording will be available for a month.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
6.4%
average across 10 past catalysts
Lead asset
ACP-211
Phase 2 · Major Depressive Disorder (MDD)

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at the UBS Global Biopharma Conference 2026 on Tuesday, November 17, 2026 at 12:40 p.m. Greenwich Mean Time.A live webcast of Acadia’s fireside chat will be accessible on the company’s website, acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following the presentation.About Acadia Pharmace

Frequently Asked Questions

When is Acadia's fireside chat at the conference?

The fireside chat is scheduled for November 17, 2026, at 12:40 p.m. GMT.

Where can I watch the live webcast?

The live webcast will be accessible on Acadia's website under the investors section.

Will there be a recording of the event?

Yes, an archived recording will be available for about one month after the presentation.

What is the UBS Global Biopharma Conference?

It is a major event where biopharma companies discuss their developments and strategies.

ShareAdd on Google
Tags: ACAD Acadia Pharmaceuticals UBS Global Biopharma Conference biopharma fireside chat live webcast
Last updated: Oct 28, 2026

Biotech snapshot

Cash runway
$956M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ACP-211Phase 2
Major Depressive Disorder (MDD) →

Catalyst track record

+24%
best trade around ACAD's most recent catalyst

Peak hindsight return over a 120-day window, across 10 tracked FDA/PDUFA catalysts for ACAD.

See every catalyst's timing & PoA →